We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Continuous Tissue Expander Helps Close Wounds

By HospiMedica staff writers
Posted on 14 May 2007
A new continuous external tissue expander assists physicians in closing chronic and acute wounds. More...


The DermaClose RC continuous external tissue expander facilitates the closure of wounds up to 15 cm in diameter by automatically expanding the skin around the wound until it is stretched enough for suturing. In most instances, the wound is ready for suturing within 24 hours; smaller wounds may require as little as an hour. After sufficient tissue expansion has occurred, the wound is sutured closed with minimal tension on the wound. For removal, the tension line is cut, and the skin staples and anchors are removed. Each DermaClose RC kit includes a skin stapler and staple remover.

The system consists of 10 skin anchors and a tension controller that applies a constant, measured pulling force, thereby expanding the skin around the wound. A clutch mechanism prevents over-tightening. The skin anchors are placed around the wound and approximately 1.5 cm from the edge of the wound, and each anchor is secured with two standard skin staples. The tension line from the tension controller is threaded around the anchors. The physician turns the tension controller knob until the spring-clutch prevents further tightening.

The system provides an excellent match of skin color- and hair-bearing qualities compared to other closure techniques, and has been shown to significantly reduce the length of scars. The DermaClose RC is a product of Wound Care Technologies (Eden Prairie, MN, USA; www.woundcaretech.com).

"DermaClose RC represents a significant advancement in assisting physicians in closing chronic and acute wounds,” said Paul Anderson, president and CEO of Wound Care Technologies. "DermaClose RC can reduce the total cost of healing wounds, and decrease risks in treating large wounds by lessening the time to closure.”


Related Links:
Wound Care Technologies

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.